Literature DB >> 2937794

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.

D F Wong, A Gjedde, H N Wagner.   

Abstract

A first step in the quantification of receptor density in the living human brain is the measurement of the binding of a labeled ligand to the receptor in question. In the present study, we determined the rate of binding of 11C-labeled N-methylspiperone (NMSP) to the D2 dopamine receptor in 11 normal volunteers, using a three-compartment model to relate the time integral of the measured plasma concentration to the distribution of the tracer in the caudate nucleus. The plasma concentrations of NMSP were separated from the contaminating metabolites by the ratio of radioactivities in cerebellum and blood plasma. Plasma concentrations calculated in this way agreed with plasma concentrations determined by HPLC. The rate of binding of labeled NMSP to its receptors (k3) was defined as the product of the bimolecular association rate (kon) and the quantity of available receptors (B'max) and calculated as the ratio between the steady-state rate of accumulation and the volume of distribution of labeled NMSP in the caudate nucleus. The average value of k3 in the 11 normal volunteers was 0.065 min-1. The fractional clearance of labeled NMSP from the caudate nucleus (k2) was 0.070 min-1 and thus close to the value of k3. We also examined several indexes of binding based on ratios between different regions in brain. The indexes required that binding be negligible compared to the efflux of labeled NMSP (i.e., k2 much greater than k3) and therefore yielded incorrectly low values of k3. Thus, the only accurate approach used measured plasma concentrations to estimate transfer constants at steady state and yielded the absolute rate of binding k3. The approach is applicable to other irreversibly bound ligands.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937794     DOI: 10.1038/jcbfm.1986.27

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

Review 1.  Functional imaging of the brain using single photon emission computerized tomography (SPECT).

Authors:  A E Todd-Pokropek
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

2.  Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.

Authors:  G Blomqvist; S Pauli; L Farde; L Eriksson; A Persson; C Halldin
Journal:  Eur J Nucl Med       Date:  1990

3.  Effects of point spread function-based image reconstruction on neuroreceptor binding in positron emission tomography study with [(11)C]FLB 457.

Authors:  Thonnapong Thongpraparn; Yoko Ikoma; Takahiro Shiraishi; Taiga Yamaya; Hiroshi Ito
Journal:  Radiol Phys Technol       Date:  2015-12-16

Review 4.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 5.  Positron emission tomography applied in the study of pituitary adenomas.

Authors:  C Muhr; M Bergström
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

Review 6.  PET: a biological imaging technique.

Authors:  M E Phelps
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 7.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

8.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

Authors:  B R Zeeberg; H N Wagner
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

9.  Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET.

Authors:  K Herholz
Journal:  Eur J Nucl Med       Date:  1988

10.  Multi-graphical analysis of dynamic PET.

Authors:  Yun Zhou; Weiguo Ye; James R Brasić; Dean F Wong
Journal:  Neuroimage       Date:  2009-11-17       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.